Cargando…
Addressing COVID-19 vaccine hesitancy
Immunization programmes have been globally recognized as one of the most successful medical interventions against infectious diseases. Despite the proven efficacy and safety profiles of coronavirus disease 2019 (COVID-19) vaccines, there are still a substantial number of people who express vaccine h...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioExcel Publishing Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9225513/ https://www.ncbi.nlm.nih.gov/pubmed/35814493 http://dx.doi.org/10.7573/dic.2021-12-3 |
_version_ | 1784733631722291200 |
---|---|
author | Kassianos, George Puig-Barberà, Joan Dinse, Hannah Teufel, Martin Türeci, Özlem Pather, Shanti |
author_facet | Kassianos, George Puig-Barberà, Joan Dinse, Hannah Teufel, Martin Türeci, Özlem Pather, Shanti |
author_sort | Kassianos, George |
collection | PubMed |
description | Immunization programmes have been globally recognized as one of the most successful medical interventions against infectious diseases. Despite the proven efficacy and safety profiles of coronavirus disease 2019 (COVID-19) vaccines, there are still a substantial number of people who express vaccine hesitancy. Factors that influence vaccine decision-making are heterogenous, complex, and context specific and may be caused or amplified by uncontrolled online information or misinformation. With respect to COVID-19, the recent emergence of novel variants of concern that give rise to milder disease also drives vaccine hesitancy. Healthcare professionals remain one of the most trusted groups to advise and provide information to those ambivalent about COVID-19 vaccination and should be equipped with adequate resources and information as well as practical guidance to empower them to effectively discuss concerns. This article seeks to summarize the currently available information to address the most common concerns regarding COVID-19 vaccination. |
format | Online Article Text |
id | pubmed-9225513 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioExcel Publishing Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-92255132022-07-08 Addressing COVID-19 vaccine hesitancy Kassianos, George Puig-Barberà, Joan Dinse, Hannah Teufel, Martin Türeci, Özlem Pather, Shanti Drugs Context Review Immunization programmes have been globally recognized as one of the most successful medical interventions against infectious diseases. Despite the proven efficacy and safety profiles of coronavirus disease 2019 (COVID-19) vaccines, there are still a substantial number of people who express vaccine hesitancy. Factors that influence vaccine decision-making are heterogenous, complex, and context specific and may be caused or amplified by uncontrolled online information or misinformation. With respect to COVID-19, the recent emergence of novel variants of concern that give rise to milder disease also drives vaccine hesitancy. Healthcare professionals remain one of the most trusted groups to advise and provide information to those ambivalent about COVID-19 vaccination and should be equipped with adequate resources and information as well as practical guidance to empower them to effectively discuss concerns. This article seeks to summarize the currently available information to address the most common concerns regarding COVID-19 vaccination. BioExcel Publishing Ltd 2022-06-20 /pmc/articles/PMC9225513/ /pubmed/35814493 http://dx.doi.org/10.7573/dic.2021-12-3 Text en Copyright © 2022 Kassianos G, Puig-Barberà J, Dinse H, Teufel M, Türeci Ö, Pather S https://creativecommons.org/licenses/by-nc-nd/4.0/Published by Drugs in Context under Creative Commons License Deed CC BY NC ND 4.0, which allows anyone to copy, distribute and transmit the article provided it is properly attributed in the manner specified below. No commercial use without permission. |
spellingShingle | Review Kassianos, George Puig-Barberà, Joan Dinse, Hannah Teufel, Martin Türeci, Özlem Pather, Shanti Addressing COVID-19 vaccine hesitancy |
title | Addressing COVID-19 vaccine hesitancy |
title_full | Addressing COVID-19 vaccine hesitancy |
title_fullStr | Addressing COVID-19 vaccine hesitancy |
title_full_unstemmed | Addressing COVID-19 vaccine hesitancy |
title_short | Addressing COVID-19 vaccine hesitancy |
title_sort | addressing covid-19 vaccine hesitancy |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9225513/ https://www.ncbi.nlm.nih.gov/pubmed/35814493 http://dx.doi.org/10.7573/dic.2021-12-3 |
work_keys_str_mv | AT kassianosgeorge addressingcovid19vaccinehesitancy AT puigbarberajoan addressingcovid19vaccinehesitancy AT dinsehannah addressingcovid19vaccinehesitancy AT teufelmartin addressingcovid19vaccinehesitancy AT tureciozlem addressingcovid19vaccinehesitancy AT pathershanti addressingcovid19vaccinehesitancy |